证券代码：600836 证券简称：上海易连 公告编号：临 2023-035 上海易连实业集团股份有限公司 关于召开 2022 年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 会议召开时间：2023 年 6 月 9 日(星期五)上午 10:00-11:00 会议召开地点：上海证券交易所上证路演中心（网址： http://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 的经营成果及财务指标的具体情况与投资者进行互动交流和沟通，在 信息披露允许的范围内就投资者普遍关注的问题进行回答。 二、说明会召开的时间、地点 （一）会议召开时间：2023 年 6 月 9 日上午 10:00-11:00 （二）会议召开地点：上海证券交易所上证路演中心（网址： http://roadshow.sseinfo.com/） （三）会议召开方式：上证路演中心网络互动 三、参加人员 董事长：柏松 投资者可于 2023 年 6 月 2 日(星期五)至 6 月 8 日(星期四)16:00 前 ...

Financial Performance - The company's operating revenue for Q1 2023 was ¥126,830,005.78, representing a decrease of 11.19% compared to the same period last year[2]. - The net profit attributable to shareholders was ¥1,231,824.78, down 43.44% year-on-year[2]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥4,300,965.61, a significant decline of 712.68%[2]. - The net cash flow from operating activities was -¥76,599,505.09, reflecting a decrease of 398.76% compared to the previous year[2]. - Basic and diluted earnings per share were both ¥0.0018, down 45.45% year-on-year[2]. - The total revenue from operating activities was CNY 1,193,006,175.56, compared to CNY 815,435,011.30 in the same period last year, indicating a year-over-year increase of about 46.2%[27]. - The company reported a total profit of CNY 7,250,023.28, down from CNY 10,592,360.42 in the previous year, reflecting a decrease of approximately 31.8%[25]. - Earnings per share (EPS) for Q1 2023 were CNY 0.0018, down from CNY 0.0033 in Q1 2022, representing a decline of about 45.5%[25]. - The total operating costs for Q1 2023 were RMB 127,777,990.14, down from RMB 132,938,182.63 in the same period last year, representing a decline of approximately 3.3%[23]. - The company reported a net investment loss of RMB 512.58 in Q1 2023, a significant improvement from a loss of RMB 1,723,855.82 in Q1 2022[23]. Assets and Liabilities - Total assets at the end of the reporting period were ¥2,032,996,428.26, a decrease of 1.35% from the end of the previous year[3]. - The company's total liabilities as of March 31, 2023, were RMB 853,048,804.15, down from RMB 884,488,317.46 at the end of 2022, indicating a reduction of about 3.5%[20]. - The total equity attributable to shareholders increased slightly to RMB 1,149,183,151.28 from RMB 1,146,573,879.35, showing a growth of approximately 0.2%[21]. - The cash and cash equivalents as of March 31, 2023, were RMB 1,115,620,852.44, an increase from RMB 999,430,445.95 at the end of 2022, reflecting a growth of approximately 11.6%[18]. - The cash and cash equivalents at the end of Q1 2023 totaled CNY 1,115,620,852.44, an increase from CNY 935,737,191.45 at the end of Q1 2022, marking a growth of approximately 19.3%[29]. Shareholder Activities - The total number of ordinary shareholders at the end of the reporting period was 33,328[6]. - Shareholders, including former chairman Zhao Hongguang, planned to increase their holdings, with a total intended investment of at least RMB 50 million[12]. - As of April 26, 2023, the total amount of shares purchased by the shareholders reached RMB 10,000,000, with specific amounts for each individual[14]. - The company plans to reduce the number of restricted shares by repurchasing and canceling 3,800,000 shares, which will decrease the total share capital from 672,753,072 shares to 668,953,072 shares[6]. Corporate Governance - The company’s board of directors underwent changes, with Bai Song elected as the new chairman[12]. - Zhao Hongguang, the former chairman, resigned from all positions within the company[11]. - The company appointed Xu Shi as the new general manager, effective from April 28, 2023, following the resignation of the previous general manager[16]. - The company’s first quarter report indicates ongoing strategic adjustments and governance improvements[9]. Investments and Subsidiaries - The company established a wholly-owned subsidiary, Beijing Yilian New Energy Co., Ltd., with an investment of RMB 200 million[11]. - The company completed the transfer of packaging printing project assets for a total price of RMB 218 million, which includes tax[10]. - The company provided a guarantee for the asset transfer transaction involving its subsidiary Zhejiang Foreign Trade[10]. - The company has completed the registration procedures for the new subsidiary, which is now officially named Beijing Yilian Xing Innovation Energy Co., Ltd.[11]. Tax and Expenses - The company reported an increase in tax expenses related to the transfer of factory land, contributing to the decline in cash flow[5]. - The company reported a decrease in income tax expenses to CNY 4,949,915.08 from CNY 8,353,332.33 in Q1 2022, a reduction of approximately 40.5%[25]. - Research and development expenses increased significantly to RMB 1,808,361.59 in Q1 2023, compared to RMB 641,038.08 in Q1 2022, marking an increase of approximately 182.5%[23].

Financial Performance - The company's operating revenue for 2022 was CNY 514,346,753.74, a decrease of 38.26% compared to CNY 833,088,414.25 in 2021[20] - The net profit attributable to shareholders of the listed company was a loss of CNY 81,000,795.02, a decline of 139.19% from a profit of CNY 206,706,065.54 in the previous year[20] - The net cash flow from operating activities was CNY 60,518,414.46, down 68.01% from CNY 189,172,479.77 in 2021[20] - The total assets at the end of 2022 were CNY 2,060,758,386.22, a decrease of 5.05% from CNY 2,170,369,575.48 at the end of 2021[20] - The net assets attributable to shareholders of the listed company were CNY 1,146,573,879.35, down 5.48% from CNY 1,213,010,197.77 in 2021[20] - Basic earnings per share decreased by 138.67% to -0.1206 yuan per share in 2022 compared to 0.3119 yuan per share in 2021[21] - The company achieved a total revenue of 142.81 million yuan in Q1 2022, with a net profit attributable to shareholders of 2.18 million yuan, but faced a net loss of 32.56 million yuan in Q4 2022[22] - The printing and packaging segment's main business revenue decreased by CNY 203.06 million, down 35.46% year-on-year[33] - The gross margin for the printing and packaging segment was 8.68%, a decrease of 3.41 percentage points compared to the previous year[39] - The company reported a significant drop in cash flow from operating activities, with a net cash flow of CNY 60.52 million, down 68.01% year-on-year[34] Operational Changes and Strategies - The company faced significant risks in its operations, which are detailed in the management discussion and analysis section of the report[7] - The company developed 21 new clients in 2022, generating an additional sales revenue of over 24 million yuan[25] - The company plans to enter the green energy sector and has initiated a partnership with Guangzhou Baobi New Energy Technology Co., Ltd. in September 2022[27] - The company is focusing on technological innovation in the printing sector, with two subsidiaries recognized as high-tech enterprises[32] - The company is committed to green and digital printing technologies to enhance its competitive edge in the market[32] - The company aims to enhance its printing industry potential by focusing on market research and product innovation, targeting a significant increase in business profit margins[68] - The company plans to accelerate its transition to the new energy sector, particularly in vanadium product production and new material technology development[70] - The company intends to improve its property management capabilities to maximize cash flow and profit, adapting to market changes[70] - The company will strengthen internal control and risk management to ensure investment safety and improve investment returns[70] Governance and Compliance - The report includes a standard unqualified audit opinion from the accounting firm Li Xin Zhong Lian[4] - The company has maintained independence in operations, assets, and financial management from its controlling shareholder, ensuring a complete governance structure[79] - The company has not engaged in non-operating fund occupation by controlling shareholders or related parties[7] - The company has not violated decision-making procedures for providing guarantees[7] - The company has a complete and reasonable internal control system to ensure compliance and safeguard shareholder interests[131] - The company has committed to maintaining independence from its controlling shareholders and related parties, ensuring no illegal occupation of funds or assets[142] - The company has faced regulatory attention due to past compliance issues, highlighting the importance of governance and oversight[102] Shareholder and Management Changes - The company held its first extraordinary general meeting on February 18, 2022, with 180,473,472 shares represented, accounting for 26.8940% of total shares[84] - The company adopted a combination of on-site and online voting methods for all meetings, ensuring compliance with legal and regulatory requirements[84][85][86][87][88] - The company decided to terminate investment in the biopharmaceutical industry base during the second extraordinary general meeting[86] - The company appointed Lai Hongbo as the new General Manager and Gu Qiu Hong as the new Deputy General Manager following the resignation of previous executives[98] - The company has undergone several changes in its board of directors, with multiple elections held to ensure proper governance[98] - The company’s supervisory board has also seen changes, with Liu Zhigang elected as the new Chairman of the Supervisory Board[99] - The company’s board of directors has been restructured to maintain operational continuity after several resignations[100] Legal and Regulatory Matters - The company received a warning letter from the China Securities Regulatory Commission on January 18, 2022, indicating regulatory scrutiny[103] - The company has been subject to regulatory measures, including a warning letter from the Shanghai Stock Exchange in March 2021[102] - The company is involved in significant litigation matters, including a case where it was ordered to pay 2,037,586 RMB in rent and overdue interest to Yangzhou Yilian[152] - The company has a total of 1,811,639.79 RMB in economic compensation payments ordered by the arbitration committee related to labor disputes[153] - The company has faced a lawsuit regarding a rental agreement, with claims totaling 768.44 million RMB currently under trial[152] - The company has successfully concluded several litigation cases, including a judgment requiring it to pay 184.28 million RMB in overdue rent and penalties[152] - The company has been subject to regulatory scrutiny due to discrepancies in governance practices, which may affect investor confidence[157] Future Outlook and Growth Plans - The company aims to achieve a revenue growth target of 15% for the upcoming fiscal year[91] - New product launches are expected to contribute significantly to revenue in the next quarter[91] - The company is expanding its market presence in Southeast Asia, targeting a 30% market share by the end of 2023[94] - A strategic acquisition of a tech startup was completed, valued at 100 million, aimed at enhancing the company's technological capabilities[94] - The company plans to invest 50 million in research and development to innovate new technologies over the next two years[94] - The management team highlighted a focus on improving operational efficiency, aiming for a 10% reduction in costs by the end of 2023[94] Environmental and Social Responsibility - The company is actively enhancing its green and environmental protection upgrades in production processes, increasing investment in technical renovations and pollution control equipment operations[73] - The company has committed to complying with new environmental regulations, including the VOCs emission standards established in 2022[73] - The company invested 640,000 CNY in environmental protection during the reporting period[134] - The company held its 2022 Annual Social Responsibility Report meeting on March 28, 2023, and announced the report on March 29, 2023[137] Share Capital and Dividends - The company has established a cash dividend policy prioritizing cash dividends over stock dividends, with a minimum cash dividend ratio of 20% for growth stage companies with significant capital expenditure plans[121] - In 2022, the company did not achieve profitability and therefore did not meet the conditions for cash dividends, resulting in no profit distribution for the year[125] - The board approved the 2022 profit distribution plan on March 28, 2023, which included no profit distribution or capital reserve transfer due to the lack of profits[125] - The company aims for a minimum cash dividend ratio of 20% during profit distribution when in a growth stage with significant capital expenditures[122] Shareholder Transactions - The largest shareholder, Zhejiang Yefan Yilian Business Management Partnership, reduced its holdings by 13,455,000 shares (2.00% of total shares) and transferred 36,668,600 shares (5.45% of total shares) at a price of 6.10 CNY per share, totaling 223,678,460 CNY[182] - As of the end of the reporting period, the total assets were 206,075.84 million CNY, total liabilities were 88,448.83 million CNY, resulting in a debt-to-asset ratio of 42.92%[182] - The number of ordinary shareholders increased from 31,935 to 32,855 during the reporting period[184] - The top ten shareholders include institutional investors and individuals, with the largest being Zhejiang Yefan Yilian and Hunan Yongxing Private Fund Management Company[186]

Financial Performance - The company's operating revenue for Q3 2022 was ¥135,531,321.86, representing a decrease of 12.58% compared to the same period last year[4]. - The net profit attributable to shareholders was -¥21,904,977.09, a decline of 137.81% year-on-year[4]. - The basic earnings per share for the year-to-date period was -¥0.073, reflecting a decrease of 137.82% compared to the previous year[5]. - Total revenue for the first three quarters of 2022 was CNY 365,042,947.64, a decrease of 37.9% compared to CNY 588,548,386.42 in the same period of 2021[30]. - Operating profit for the third quarter of 2022 was a loss of CNY 38,000,285.88, compared to a profit of CNY 161,523,924.00 in the same quarter of 2021[31]. - The net profit for Q3 2022 was -51,535,882.74 RMB, compared to a net profit of 129,232,190.48 RMB in Q3 2021, indicating a significant decline[32]. - The basic and diluted earnings per share for Q3 2022 were both -0.073 RMB, down from 0.193 RMB in Q3 2021[33]. - The company reported a total comprehensive income attributable to the parent company of -48,445,684.05 RMB in Q3 2022, compared to 128,127,360.23 RMB in Q3 2021[33]. Assets and Liabilities - The total assets at the end of the reporting period were ¥2,108,268,268.92, down 2.86% from the end of the previous year[5]. - Total assets as of September 30, 2022, were CNY 2,108,268,268.92, down from CNY 2,170,369,575.48 at the end of 2021[29]. - Total liabilities as of September 30, 2022, were CNY 908,609,501.76, slightly down from CNY 908,978,819.14 at the end of 2021[29]. - Shareholders' equity decreased to CNY 1,199,658,767.16 from CNY 1,261,390,756.34, a decline of 4.9%[29]. Cash Flow - The cash flow from operating activities for the year-to-date period was ¥46,012,757.30, showing a slight increase of 1.96% year-on-year[4]. - Cash flow from operating activities for the first nine months of 2022 was 46,012,757.30 RMB, slightly up from 45,126,963.65 RMB in the same period of 2021[34]. - Cash inflow from investment activities in Q3 2022 totaled 37,331,344.39 RMB, a decrease from 339,765,644.89 RMB in Q3 2021[35]. - The net cash flow from financing activities in Q3 2022 was -66,018,187.45 RMB, compared to a positive cash flow of 165,855,362.28 RMB in Q3 2021[35]. - The total cash and cash equivalents at the end of Q3 2022 were 937,215,236.61 RMB, down from 741,738,443.79 RMB at the end of Q3 2021[35]. Shareholder Information - The company had a total of 31,907 common shareholders at the end of the reporting period[10]. - The largest shareholder, Hangzhou Zhefa Yilian Business Management Partnership, holds 180,468,652 shares, accounting for 26.83% of total shares, with 127,500,000 shares pledged[11]. Strategic Decisions - The company plans to invest 150 million RMB in its wholly-owned subsidiary, which has been renamed to Shanghai Yilian Green Energy Business Consulting Co., Ltd., to engage in carbon reduction projects[13]. - The company has decided to abandon its transition to the healthcare sector and has returned land use rights for a 106,625 square meter plot, receiving a compensation of 40.73 million RMB[14]. - The company terminated its investment in the biomedical industry base and the non-public offering of A-shares due to changes in the internal and external environment[15]. - The company intended to acquire at least 30% of Shanghai Baochar New Energy Environmental Technology Co., Ltd., with an estimated valuation of no less than 450 million RMB, but ultimately decided to terminate the acquisition[17]. - The company approved the transfer of assets from its wholly-owned subsidiary Zhejiang Foreign Trade to Shanghai Haiyouwei New Materials Co., Ltd. for a total price of 218 million RMB (including tax) on September 27, 2022[18]. Incentive Plans - The company granted 1.7 million restricted stock units to an incentive object at a price of 3.23 RMB per share, increasing the total number of shares from 671,053,072 to 672,753,072[19]. - The company adjusted the performance assessment requirements and the assessment years for its 2021 restricted stock incentive plan, now covering 2021, 2023, and 2024[20]. - The first unlock period for the 2021 restricted stock incentive plan was achieved, allowing for the release of 2.49 million shares[21]. - The company announced a plan for key executives to increase their shareholdings by at least 50 million RMB, with specific amounts designated for each individual[22]. - The shareholding increase plan was extended by six months due to the impact of COVID-19 and other factors, now set to conclude on April 26, 2023[23]. Legal Matters - The company faced legal challenges regarding rental income claims, with courts ruling in favor of the company in multiple cases[24][25][26]. Operational Metrics - Total operating costs for the first three quarters of 2022 were CNY 407,510,258.31, down 33.8% from CNY 615,398,126.25 in 2021[31]. - Research and development expenses for the first three quarters of 2022 were CNY 3,123,124.82, down 53.3% from CNY 6,690,179.00 in the same period of 2021[31]. - Cash and cash equivalents as of September 30, 2022, were CNY 937,215,236.61, slightly down from CNY 948,672,786.31 at the end of 2021[28]. - Accounts receivable increased to CNY 165,007,742.48 as of September 30, 2022, from CNY 136,323,602.50 at the end of 2021, representing a growth of 21.1%[28]. - Inventory decreased to CNY 89,548,067.33 from CNY 98,263,399.04, a decline of 8.7%[28].

Financial Performance - The company's operating revenue for the first half of 2022 was ¥229,511,625.78, a decrease of 47.06% compared to ¥433,519,731.09 in the same period last year[18]. - The net profit attributable to shareholders for the first half of 2022 was -¥26,540,706.96, representing a decline of 118.17% from ¥146,042,563.65 in the previous year[18]. - Basic earnings per share for the first half of 2022 were -¥0.040, down 118.18% from ¥0.220 in the same period last year[18]. - The company reported a net cash flow from operating activities of CNY 69.64 million, a significant improvement compared to CNY -2.54 million in the previous year[33]. - The company experienced a decrease in investment cash flow net amounting to CNY -26.87 million, down from CNY 232.54 million in the previous year[33]. - The financing cash flow net decreased by CNY -36.29 million, compared to an inflow of CNY 139.38 million in the previous year[33]. - The company reported a significant decrease in investment income, which fell to CNY 56,617,103.57 from CNY 177,642,030.46 in the first half of 2021, a decline of 68.1%[106]. - The company reported a comprehensive income loss of -26,540,706.96 RMB for the period[116]. Assets and Liabilities - The total assets at the end of the reporting period were ¥2,165,997,696.47, a slight decrease of 0.20% from ¥2,170,369,575.48 at the end of the previous year[18]. - The company's net assets attributable to shareholders decreased by 1.98% to ¥1,189,044,643.54 from ¥1,213,010,197.77 at the end of the previous year[18]. - Total liabilities rose to CNY 724.11 million in the first half of 2022, compared to CNY 692.30 million in the same period of 2021[100]. - The total liabilities as of June 30, 2022, were RMB 947,283,091.00, compared to RMB 908,978,819.14 at the beginning of the period, representing an increase of approximately 4.2%[96]. - The total amount of guarantees provided by the company, including those to subsidiaries, is 37,460 million RMB, which accounts for 31.50% of the company's net assets[72]. Operational Changes and Strategies - The company is focusing on technological innovation and green environmental practices in the packaging printing sector, with a commitment to developing wide-format high-definition flexographic printing technology[26]. - The company is focusing on a business transformation strategy, emphasizing policy tracking and talent development to mitigate risks associated with the transition[42]. - The company aims to establish a standardized operational management system to enhance efficiency across various processes[42]. - The company plans to attract and cultivate high-caliber talent to support its new industry development needs[42]. - The company will actively enhance green and environmentally friendly upgrades in production processes, increasing investment in technical renovations and pollution control equipment operations[44]. - The company aims to adjust its functional positioning and innovate profit models to address new market competition as it enters new industry sectors[43]. - The company plans to strengthen communication and coordination between business, technical, and production departments to adapt to market changes[43]. Shareholder and Management Information - The company held its first temporary shareholders' meeting on February 18, 2022, with 26.89% of voting shares represented[47]. - The company appointed new senior management, including hiring a new general manager and vice general manager following the resignation of previous executives[50]. - The management team remains unchanged, with Zhao Hongguang as the company leader and Yang Guang as the head of accounting[118]. Legal and Compliance Issues - The company received a warning from the China Securities Regulatory Commission for failing to disclose significant contract information in a timely manner, affecting its governance compliance[65]. - The company is involved in significant litigation, with a total amount of 1,811,639.79 RMB ordered for labor compensation in a case against its subsidiary, Shanghai Hanfang Development Co., Ltd.[62]. - The company has ongoing appeals in multiple labor dispute cases, including a ruling to pay 621,135.83 RMB to one former employee and 238,987.50 RMB to another, with the appeals being rejected by the court[63]. Investment and Acquisitions - The company plans to acquire at least 30% equity in Shanghai Bao Carbon New Energy Environmental Technology Co., with an estimated overall valuation of no less than 450 million RMB[75]. - The formal implementation of the acquisition is subject to further negotiations based on audit and evaluation results, requiring board and shareholder approval[75]. - The exclusivity lock-in period for the acquisition has been extended from March 31, 2022, to September 30, 2022, due to delays caused by the Shanghai pandemic[76]. Environmental Compliance - The company has not faced any significant administrative penalties related to environmental violations during the reporting period[58]. - The company has adhered to national environmental protection laws and regulations without any major violations[58]. - The company will implement VOCs governance and comprehensive emission reduction measures in compliance with national environmental policies[44]. Financial Reporting and Accounting Practices - The company adheres to the accounting standards set by the Ministry of Finance, ensuring accurate financial reporting[132]. - The consolidated financial statements are prepared based on the financial statements of the parent company and its subsidiaries, reflecting the overall financial position, operating results, and cash flows of the entire group[138]. - The company recognizes its share of jointly controlled assets and liabilities in a joint operation, and accounts for related income and expenses accordingly[143]. - Revenue is recognized when the company fulfills its performance obligations, which occurs when the customer gains control of the related goods or services[198].

Financial Performance - The company's operating revenue for Q1 2022 was CNY 142,808,254.98, representing a decrease of 43.86% compared to the same period last year[2]. - The net profit attributable to shareholders was CNY 2,177,963.54, down 69.21% year-on-year[2]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 701,997.47, a decline of 86.34% compared to the previous year[2]. - The basic earnings per share were CNY 0.003, reflecting a decrease of 72.73% year-on-year[2]. - Total operating revenue for Q1 2022 was ¥142,808,254.98, a decrease of 43.8% compared to ¥254,369,056.53 in Q1 2021[16]. - Net profit for Q1 2022 was ¥2,239,028.09, a decline of 70.4% from ¥7,558,842.27 in Q1 2021[17]. - Total comprehensive income for Q1 2022 was ¥2,239,028.09, down from ¥7,558,842.27 in Q1 2021[17]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 2,253,003,734.73, an increase of 3.81% from the end of the previous year[3]. - As of March 31, 2022, the company's total assets amounted to approximately CNY 2.25 billion, an increase from CNY 2.17 billion at the end of 2021, reflecting a growth of about 3.8%[12]. - Total liabilities as of Q1 2022 amounted to ¥986,709,650.30, an increase from ¥908,978,819.14 in the previous year[17]. - The total current liabilities were reported at CNY 715.58 million, with short-term borrowings at CNY 476.53 million, a slight decrease from CNY 496.72 million at the end of 2021[12]. Cash Flow - The net cash flow from operating activities was CNY 25,639,497.64, with no applicable year-on-year comparison[2]. - In Q1 2022, the net cash flow from operating activities was ¥25,639,497.64, a significant improvement compared to a net cash outflow of ¥51,692,580.93 in Q1 2021[19]. - Total cash inflow from operating activities in Q1 2022 was ¥822,788,092.56, down 23.4% from ¥1,073,214,140.23 in Q1 2021[19]. - Cash outflow from operating activities decreased to ¥797,148,594.92 in Q1 2022, compared to ¥1,124,906,721.16 in Q1 2021, reflecting a reduction of 29.1%[19]. - The net cash flow from financing activities was negative at -¥34,429,654.42 in Q1 2022, contrasting with a positive cash flow of ¥138,049,473.35 in Q1 2021[20]. Shareholder Information - The company had a total of 33,811 common shareholders at the end of the reporting period[6]. - The largest shareholder, Hangzhou Zhefayilian Business Management Partnership, held 180,468,652 shares, accounting for 26.89% of the total shares, with 127,500,000 shares pledged[6]. - The first major shareholder holds 180,468,652 shares, accounting for 26.89% of the total share capital, with 127,500,000 shares pledged, representing 70.65% of their holdings[8]. Operational Insights - The decline in revenue and profit was primarily due to the impact of the pandemic on the printing and packaging sector and the commercial service sector[4]. - The company is actively conducting nationwide research and planning for pharmaceutical industry and product targets, indicating a strategic focus on market expansion[9]. - The company has signed a letter of intent to acquire at least 30% of Shanghai Baocan New Energy Environmental Technology Co., with an estimated valuation of no less than CNY 450 million[9]. - The company has completed the acquisition of land use rights for a biopharmaceutical industrial base project, covering approximately 106,625 square meters (about 160 acres)[9]. Cost Management - Total operating costs for Q1 2022 were ¥132,938,182.63, down 46.0% from ¥247,160,602.47 in Q1 2021[16]. - Research and development expenses for Q1 2022 were ¥641,038.08, significantly lower than ¥3,450,848.42 in Q1 2021, indicating a reduction in R&D investment[16]. - The company reported a decrease in sales expenses to ¥2,402,331.50 from ¥7,145,294.70 in the previous year, reflecting cost-cutting measures[16].

Financial Performance - In 2021, the company's operating revenue was ¥833,088,414.25, a decrease of 62.02% compared to ¥2,193,293,041.73 in 2020[19] - The net profit attributable to shareholders was ¥206,706,065.54, down 12.00% from ¥234,904,818.54 in the previous year[19] - The net profit after deducting non-recurring gains and losses increased by 47.78% to ¥27,171,047.51 from ¥18,386,324.58 in 2020[19] - The company's total assets at the end of 2021 were ¥2,170,369,575.48, an increase of 8.60% from ¥1,998,461,410.19 at the end of 2020[19] - The net assets attributable to shareholders increased by 20.01% to ¥1,213,010,197.77 from ¥1,010,729,663.24 in 2020[19] - Basic earnings per share decreased by 11.86% to ¥0.312 from ¥0.354 in 2020[20] - The weighted average return on equity decreased by 7.76 percentage points to 18.57% from 26.33% in the previous year[20] - The company reported a net cash flow from operating activities of ¥189,172,479.77, a decrease of 19.30% from ¥234,408,165.78 in 2020[19] Business Operations - The company achieved a notable increase in its fast-moving consumer goods business, particularly in the eco-friendly paper bag segment, which is expected to drive revenue growth in 2022[26] - The company successfully completed the transfer of control in April 2021, leading to the removal of the delisting risk warning and a name change to "Shanghai Yilian" in June 2021[27] - The company is actively exploring acquisition targets in the pharmaceutical sector and has secured land for a new biopharmaceutical base, covering an area of 106,625 square meters[28] - The company received government subsidies totaling ¥202.6 million for high-tech projects, supporting its strategic transformation efforts[26] - The company has implemented refined management and technological innovations in its printing operations, resulting in improved production efficiency and quality[27] Revenue Breakdown - The main business revenue from the printing and packaging segment decreased by 23.15%, amounting to a reduction of 172.53 million yuan[34] - The company's real estate segment saw a significant revenue drop of 99.60%, leading to a profit reduction of 97.21 million yuan[35] - The printing and packaging segment increased profits by 22.76 million yuan, driven by new business expansion and adjustments to loss-making subsidiaries[38] - The commercial service sector saw a significant increase in revenue to CNY 205.09 million, with a gross margin of 76.08%, up 313.51% year-over-year[41] - The production of food and beverage packaging increased by 45.55% year-over-year, with sales up 32.42%[42] Strategic Initiatives - The company aims to diversify its operations while maintaining its competitive edge in the packaging printing industry[32] - The company is focusing on technological innovation in the printing sector, including the application of wide-format high-definition flexographic printing technology[33] - The company plans to accelerate its transformation by seeking potential acquisitions or partnerships within the industry to establish a diversified business model[79] - The company is committed to enhancing its operational management through standardization across various processes, including production and financial management[80] - The company aims to attract and cultivate high-caliber talent to support its new industry direction and enhance overall workforce efficiency[80] Corporate Governance - The company maintains a complete separation from its controlling shareholder in terms of personnel, assets, finance, and business operations, ensuring independent operation[86] - The company has established a complete marketing system across its subsidiaries, ensuring that business operations do not rely on the controlling shareholder[87] - The company has a dedicated human resources department responsible for employee assessment, training, and salary review, ensuring independent personnel management[87] - The company is actively engaging in stock incentive plans to align management interests with shareholder value[99] - The company is committed to transparency in reporting executive compensation and shareholding changes, reflecting good corporate governance practices[97] Shareholder Meetings - The company held its first extraordinary general meeting on February 3, 2021, with 180,837,180 shares represented, accounting for 27.29% of the total voting shares[90] - The second extraordinary general meeting on March 18, 2021, had 185,614,824 shares represented, which is 28.01% of the total voting shares[91] - The annual general meeting on May 20, 2021, saw 181,075,824 shares represented, making up 27.32% of the total voting shares[92] - The company approved a proposal to provide guarantees for bank loans for a subsidiary during the first extraordinary general meeting[90] - The company approved the investment in a new biopharmaceutical industrial base during the third extraordinary general meeting[93] Legal and Regulatory Matters - The company received a warning letter from the China Securities Regulatory Commission on January 7, 2021, regarding administrative regulatory measures[116] - On January 18, 2022, the company received another warning letter from the China Securities Regulatory Commission, indicating ongoing regulatory scrutiny[117] - The company has faced regulatory scrutiny from the Shanghai Stock Exchange and the China Securities Regulatory Commission due to issues related to timely disclosures and governance discrepancies[168] - The company received a total of 36 civil lawsuits related to securities false statements, with 31 cases allowing the plaintiffs to withdraw their lawsuits, 2 cases dismissed, and 3 cases upheld on appeal[163] - The company was ordered to pay a total of CNY 1,956,489.79 in economic compensation to former employees following arbitration rulings[164] Employee and Compensation - The total number of employees in the parent company and major subsidiaries is 885, with 59 in the parent company and 826 in subsidiaries[133] - The workforce consists of 518 production personnel, 61 sales personnel, 22 technical personnel, 43 financial personnel, 175 administrative personnel, and 66 workshop management personnel[133] - Total compensation for all directors, supervisors, and senior management reached RMB 5.8523 million by the end of the reporting period[107] - The company has a cash dividend policy that mandates a minimum of 20% of distributable profits to be allocated as cash dividends during periods of significant capital expenditure[136] - The company has not conducted any profit distribution for the fiscal year 2020 and 2021, focusing instead on operational and developmental needs[139] Stock and Equity Transactions - The company completed the transfer of 180,468,652 shares (27.23% of total equity) from its former largest shareholder, Jielong Group, to Lishui Zhefayilian Business Management Partnership, with the transaction fully settled during the reporting period[172] - The company received a total of RMB 558 million from the transfer of a 10% stake in Shanghai Jielong Construction Engineering Co., Ltd. to Jielong Group, with the transaction completed and registered[172] - The company has provided guarantees totaling RMB 39,340 million, which accounts for 32.43% of its net assets[176] - The company has completed the registration of a capital increase of RMB 600 million in Beijing Jielong International Trade Co., Ltd., with the ownership structure changing to 45.45% for the company and 54.55% for the actual controller[172] - The company has approved a non-public offering of 100 million shares at a price of RMB 5.11 per share, with the controlling shareholder as the subscriber[187]

Financial Performance - The company's operating revenue for Q3 2021 was ¥155,028,655.33, a decrease of 48.11% compared to the same period last year[2]. - The net profit attributable to shareholders was -¥17,915,203.42, representing a decline of 519.65% year-on-year[2]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥25,686,659.09, with a year-on-year change of -303.87%[2]. - Total operating revenue for the first three quarters of 2021 was CNY 588,548,386.42, a significant decrease from CNY 1,901,605,047.27 in the same period of 2020, representing a decline of approximately 69.0%[24]. - The net profit for Q3 2021 was CNY 129,232,190.48, a decrease of 49.6% compared to CNY 255,979,773.60 in Q3 2020[25]. - The operating profit for Q3 2021 was CNY 161,523,924.00, down from CNY 278,897,583.75 in the same period last year, reflecting a decline of 42.3%[25]. - Basic and diluted earnings per share for Q3 2021 were both CNY 0.193, down from CNY 0.342 in Q3 2020, reflecting a decrease of 43.7%[27]. - The total comprehensive income for Q3 2021 was CNY 129,232,190.48, a decrease of 49.6% from CNY 255,979,773.60 in Q3 2020[26]. Cash Flow and Assets - The net cash flow from operating activities for the year-to-date was ¥45,126,963.65, an increase compared to the previous year[2]. - The company's cash and cash equivalents increased to CNY 748,238,443.80 as of September 30, 2021, up from CNY 250,324,357.17 at the end of 2020, marking a rise of about 198.5%[20]. - The cash flow from operating activities for the first three quarters of 2021 was CNY 45,126,963.65, compared to CNY 532,049.35 in the same period last year, indicating a substantial improvement[28]. - The company reported a net cash inflow from investing activities of CNY 232,452,975.99 for the first three quarters of 2021, up from CNY 127,418,571.37 in the previous year[29]. - The company achieved a net cash inflow from financing activities of CNY 165,855,362.28 in Q3 2021, compared to a net outflow of CNY 184,972,377.41 in Q3 2020[29]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 36,757[9]. - The largest shareholder, Hangzhou Zhefa Yilian Business Management Partnership (Limited Partnership), holds 180,468,652 shares, accounting for 27.23% of total shares[9]. - The first ten shareholders do not have any associated relationships with each other, and the company is unaware of any other shareholders' relationships[10]. Equity and Stock Plans - The company plans to issue 100 million A-shares at a price of 5.11 RMB per share, subject to approval by the China Securities Regulatory Commission[14]. - The company has approved a stock incentive plan involving 10 million restricted stocks, with 8.3 million stocks to be granted initially[15]. - The company will hold a shareholder meeting on October 28, 2021, to review the stock incentive plan and related matters[16]. Liabilities and Assets - Total assets at the end of the reporting period were ¥2,040,079,633.82, an increase of 2.08% from the end of the previous year[3]. - The company's total liabilities decreased to CNY 859,386,626.96 as of September 30, 2021, down from CNY 933,957,646.65 at the end of 2020, indicating a reduction of about 7.9%[22]. - The company's short-term borrowings increased to CNY 447,929,163.89 as of September 30, 2021, compared to CNY 256,016,919.85 at the end of 2020, representing an increase of approximately 75.0%[22]. - The company's non-current assets totaled CNY 941,447,476.42 as of September 30, 2021, compared to CNY 907,334,187.28 at the end of 2020, reflecting an increase of approximately 3.8%[21]. Operational Changes - The significant decrease in operating revenue was primarily due to reduced income from real estate projects compared to the previous year[6]. - The company reported a decrease in net profit due to lower investment income from equity transfers and real estate projects[6]. - The company experienced a net cash flow increase due to reduced payments for accounts payable compared to the previous year[6]. - The company has completed the acquisition of a land use right for a biopharmaceutical industrial base project covering 106,625 square meters (approximately 160 acres) in JianDe City[18]. - The company is actively conducting nationwide research and planning for pharmaceutical industry and product targets, with ongoing preliminary preparations for the project[18]. - The company completed the internal transfer of 100% equity of subsidiaries Shanghai Xundian Yutian Printing Co., Ltd. and Shanghai Xundian Yongfa Packaging Printing Co., Ltd. for a transfer price of 0 RMB each[11]. - The company transferred 100% equity of Zhejiang Jielong Yutian Packaging Co., Ltd. to Beijing Jielong International Trade Co., Ltd. for a price of 5 million RMB, with the payment fully received[12]. Legal Matters - The company has received a total of 36 civil lawsuits related to securities false statements, with 31 cases allowing the plaintiffs to withdraw their lawsuits[17].

Financial Performance - The company's operating revenue for the first half of 2021 was approximately ¥433.52 million, a decrease of 72.95% compared to ¥1.60 billion in the same period last year[22]. - The net profit attributable to shareholders for the first half of 2021 was approximately ¥146.04 million, down 34.24% from ¥222.07 million in the previous year[22]. - The basic earnings per share for the first half of 2021 was ¥0.220, a decline of 34.33% compared to ¥0.335 in the same period last year[20]. - The weighted average return on net assets decreased to 13.48%, down 11.52 percentage points from 25.00% in the previous year[20]. - The net cash flow from operating activities was negative at approximately -¥2.54 million, compared to -¥69.34 million in the same period last year[22]. - The company's total assets at the end of the reporting period were approximately ¥1.98 billion, a slight decrease of 0.79% from ¥1.99 billion at the end of the previous year[22]. - The net assets attributable to shareholders increased by 14.45% to approximately ¥1.16 billion from ¥1.01 billion at the end of the previous year[22]. - The company reported non-recurring gains of approximately ¥144.49 million during the reporting period[21]. - The printing industry's operating profit margin for the first half of 2021 was 5.21%, down from 6.43% for the entire previous year, indicating a decline of 1.22 percentage points[26]. - The loss ratio in the printing industry increased to 21.8% in June 2021, up from 16.3% at the end of 2020, reflecting a worsening trend[26]. Investment and Expansion - The company plans to invest no less than 600 million yuan to establish a biopharmaceutical industrial base in the health industry[27]. - The company has secured approximately 160 acres of land use rights in JianDe City for its strategic expansion into the health industry[27]. - The company completed the transfer of equity in five subsidiaries, generating an investment income of 177.7 million yuan, which is a decrease of 36.81 million yuan compared to the same period last year[31]. - The company is focusing on the medical health industry, monitoring national policies, and enhancing talent acquisition to mitigate transformation risks[57]. - The company aims to establish a standardized operational management system to improve efficiency across various departments[58]. Corporate Governance and Meetings - The company held its first extraordinary general meeting on February 3, 2021, with 180,837,180 shares represented, accounting for 27.29% of the total voting shares[63]. - The second extraordinary general meeting took place on March 18, 2021, with 185,614,824 shares represented, which is 28.01% of the total voting shares[64]. - The annual general meeting on May 20, 2021, had 181,075,824 shares represented, making up 27.32% of the total voting shares[65]. - The third extraordinary general meeting was held on June 7, 2021, with 180,852,362 shares represented, representing 27.29% of the total voting shares[67]. - The company approved a proposal to provide guarantees for a bank loan application for a subsidiary during the first extraordinary general meeting[63]. - The company approved a proposal to change the accounting firm for the year 2020 during the second extraordinary general meeting[64]. - The company approved multiple resolutions during the annual general meeting, including the annual report and profit distribution plan for 2020[65]. - The company announced the election of new directors and independent directors during the various general meetings[68]. Legal and Regulatory Matters - The company has no significant litigation or arbitration matters during the reporting period[78]. - The company has not received any administrative penalties for environmental issues during the reporting period[75]. - The company received a warning letter from the China Securities Regulatory Commission due to failure to disclose asset impairment losses totaling 1,046.59 million yuan, which represented 95.40% of the net profit attributable to shareholders for the previous fiscal year[85]. - The company has ongoing litigation related to securities false statements, with some cases already dismissed and others still in appeal[83]. - The company was under regulatory scrutiny due to the issuance of warning letters regarding its financial disclosures and management practices[86]. Financial Position and Equity - The company's total equity as of June 30, 2021, was RMB 1,299,750,326.85, compared to RMB 1,138,919,044.51 at the end of 2020, representing an increase of approximately 14%[118]. - The total equity attributable to shareholders was CNY 1,305,158,410.93 as of June 30, 2021, up from CNY 1,168,432,037.98 at the end of 2020, reflecting an increase of approximately 12%[123]. - The total owner's equity at the end of the reporting period is CNY 1,305,158,410.93, an increase from CNY 1,168,432,037.98 at the beginning of the year, reflecting a growth of approximately 11.7%[144]. - The comprehensive income for the period amounted to CNY 136,726,372.95, contributing significantly to the increase in owner's equity[144]. - The company's retained earnings increased to CNY 420,938,288.13, up from CNY 284,211,915.18 at the beginning of the year, indicating a growth of approximately 48.1%[144]. Cash Flow and Liquidity - The company's cash and cash equivalents increased to RMB 667,689,979.58 from RMB 250,324,357.17 at the end of 2020, representing a growth of 167%[117]. - The total cash and cash equivalents at the end of the period amounted to CNY 24,826,170.80, a decrease from CNY 37,870,441.63 at the end of the previous year[137]. - Cash inflow from investment activities was CNY 480,626,055.74, compared to CNY 191,114,512.00 in the previous year[137]. - Cash outflow from investment activities totaled CNY 3,925,655.23, compared to CNY 38,939,211.76 in the same period last year[137]. - The company reported a total of CNY 667,689,979.58 in cash and cash equivalents at the end of the reporting period[134]. Accounting Policies and Practices - The financial statements are prepared based on the going concern principle, with no significant doubts regarding the company's ability to continue operations for the next 12 months[153]. - The accounting policies comply with the accounting standards issued by the Ministry of Finance, ensuring a true and complete reflection of the company's financial status as of June 30, 2021[155]. - The company uses Renminbi as its functional currency for accounting purposes[158]. - The consolidation scope includes all subsidiaries under the company's control, reflecting the overall financial status and performance of the group[160]. - The company has not reported any changes in the consolidation scope during the reporting period[162].

Financial Performance - Operating revenue decreased by 81.73% to CNY 254,369,056.53 compared to the same period last year[13] - Net profit attributable to shareholders decreased by 96.94% to CNY 7,074,109.20 compared to the same period last year[6] - Basic earnings per share decreased by 96.85% to CNY 0.011 per share[6] - Net profit for Q1 2021 was 7,558,842.27 RMB, a decrease of 97.07% compared to the same period last year[14] - Total operating revenue for Q1 2021 was ¥254,369,056.53, a decrease of 81.7% compared to ¥1,391,957,155.17 in Q1 2020[29] - Total profit for Q1 2021 was ¥10,441,835.39, a decrease of 96.5% from ¥300,003,898.39 in Q1 2020[29] - The company reported a significant increase in cash received from sales of goods and services, amounting to CNY 1,064,661,358.66 in Q1 2021, compared to CNY 230,701,658.37 in Q1 2020[34] Assets and Liabilities - Total assets increased by 7.28% to CNY 2,143,934,969.36 compared to the end of the previous year[6] - Current liabilities rose to CNY 959,745,451.37, compared to CNY 859,175,508.66, indicating an increase of about 11.7%[22] - Non-current liabilities totaled CNY 112,126,912.18, up from CNY 74,782,137.99, reflecting a significant increase of approximately 49.8%[23] - Total liabilities increased to CNY 1,071,872,363.55, up from CNY 933,957,646.65, representing a growth of approximately 14.8%[23] - Owner's equity reached CNY 1,072,062,605.81, compared to CNY 1,064,503,763.54, showing a slight increase of about 0.7%[23] Cash Flow - Cash flow from operating activities improved to CNY -51,692,580.93 from CNY -74,605,658.51 in the same period last year[6] - Cash inflows from operating activities reached CNY 1,073,214,140.23 in Q1 2021, a substantial increase from CNY 234,484,383.19 in Q1 2020, reflecting improved sales performance[35] - The net cash flow from operating activities was negative at CNY -51,692,580.93 in Q1 2021, although it improved from CNY -74,605,658.51 in Q1 2020[35] - The company generated CNY 409,762,607.91 in cash inflows from financing activities in Q1 2021, compared to CNY 70,098,883.85 in Q1 2020, showing a strong increase in financing efforts[36] - The net cash flow from financing activities was CNY 138,049,473.35 in Q1 2021, a recovery from CNY -42,288,096.32 in Q1 2020[35] Research and Development - Research and development expenses increased by 73.90% to CNY 3,450,848.42 compared to the same period last year[13] - Research and development expenses increased due to higher spending in the printing and packaging sector[14] Shareholder Information - The number of shareholders reached 38,438 at the end of the reporting period[10] - The company completed the transfer of 180,468,652 shares (27.23% of total shares) to Zhejiang Yilian, with a transaction value of 1.4 billion RMB[16] Government Support - The company received government subsidies amounting to CNY 608,408.69 related to its normal business operations[6] - The company recorded an increase in other income due to government subsidies compared to the previous year[14]